Table 2. Trend and Level Changes of Study Outcomes Due to Reimbursement Changes .
| BMD Exam | AOMs Prescriptions | Subsequent Fracture | Fracture Related Cost | |||||
|
Level Change
%, (95% CI) |
Trend Change
%, (95% CI) |
Level Change
%, (95% CI) |
Trend Change
%, (95% CI) |
Level Change
%, (95% CI) |
Trend Change
%, (95% CI) |
Level Change
USD, (95% CI) |
Trend Change
USD, (95% CI) |
|
| Female, age (y) | ||||||||
| 50-64y | 6.5*** (3.8, 9.2) |
0.3** (0.1, 0.5) |
-13.0*** (-18.0, -7.7) |
-0.2 (-0.6, 0.3) |
-2.5 (-5.5, 0.4) |
-0.3 (-0.3, 0.3) |
-188* (-335, -40) |
23** (9, 37) |
| 65-79 | 10.5*** (8.8, 12.3) |
0.2** (0.1, 0.4) |
-5.6 (-10.2, -0.9) |
-0.3 (-0.8, 0.2) |
-0.4 (-2.7, 1.9) |
-0.1 (-0.3, 0.1) |
-249*** (-304, -194) |
1 (-4, 6) |
| +80 | 8.0*** (5.7, 10.2) |
0.2* (0.1, 0.4) |
-6.8** (-10.7, -2.9) |
-0.2 (-0.6, 0.1) |
1.4 (-0.9, 3.7) |
-0.1 (-0.3, 0.1) |
139** (55, 224) |
19*** (11, 27) |
| Male, age (y) | ||||||||
| 50-64 | 2.0* (0.1, 4.0) |
0.2** (0.1, 0.4) |
-5.7*** (-8.1, -3.4) |
-0.2 (-0.4, 0.0) |
0.2 (-3.5, 4.0) |
-0.1 (-0.5, 0.3) |
-29 (-118, 60) |
9* (0.1, 17) |
| 65-79 | 6.5*** (4.4, 8.5) |
0.2** (0.1, 0.4) |
-8.9*** (-12.3, -5.6) |
-0.3* (-0.6, -0.0) |
1.1 (-0.9, 3.2) |
-0.0 (-0.2, 0.2) |
-64 (-150, 23) |
6 (-2, 14) |
| +80 | 4.7*** (3.1, 6.2) |
0.3** (0.1, 0.4) |
-9.2*** (-12.9, -5.6) |
-0.2 (-0.5, 0.1) |
0.1 (-1.3, 1.5) |
0.0 (-0.1, 0.2) |
168*** (76, 260) |
18*** (9, 27) |
Abbreviations: AOMs, anti-osteoporosis medications; BMD, bone mineral density.
*** P ≤.001, ** P ≤.01, * P ≤.05.